Related references
Note: Only part of the references are listed.Single nucleotide variation in the TP53 3′ untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program
Yong Li et al.
BLOOD (2013)
Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222
V. Enciso-Mora et al.
BRITISH JOURNAL OF CANCER (2013)
Tobacco smoking and risk of multiple myeloma: A meta-analysis of 40 observational studies
Theodora Psaltopoulou et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Off-Target Effect of Endogenous siRNA Derived from RMRP in Human Cells
Yoshiko Maida et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Association between a rare novel TP53 variant (rs78378222) and melanoma, squamous cell carcinoma of head and neck and lung cancer susceptibility in non-Hispanic Whites
Xiaoxiang Guan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
Impact of deleterious passenger mutations on cancer progression
Christopher D. McFarland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
No association between cigarette smoking and incidence of plasma cell myeloma: A meta-analysis of 17 observational studies
Jorge J. Castillo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
Zijun Y. Xu-Monette et al.
BLOOD (2012)
A functional germline variant in the P53 polyadenylation signal and risk of esophageal squamous cell carcinoma
Liqing Zhou et al.
GENE (2012)
Rare TP53 genetic variant associated with glioma risk and outcome
Kathleen M. Egan et al.
JOURNAL OF MEDICAL GENETICS (2012)
A Systematic Screen Reveals MicroRNA Clusters That Significantly Regulate Four Major Signaling Pathways
Lindsey E. Becker et al.
PLOS ONE (2012)
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
Jens G. Lohr et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival
Jianxiang Chi et al.
BIOLOGY DIRECT (2011)
Genetic architecture of cancer and other complex diseases: lessons learned and future directions
Lucia A. Hindorff et al.
CARCINOGENESIS (2011)
Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic Leukemia
Muller Fabbri et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
MicroRNA signatures characterize multiple myeloma patients
S. L. Corthals et al.
LEUKEMIA (2011)
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Ryan D. Morin et al.
NATURE (2011)
Analysis of the coding genome of diffuse large B-cell lymphoma
Laura Pasqualucci et al.
NATURE GENETICS (2011)
A germline variant in the TP53 polyadenylation signal confers cancer susceptibility
Simon N. Stacey et al.
NATURE GENETICS (2011)
Negative regulation of the tumor suppressor p53 gene by microRNAs
M. Kumar et al.
ONCOGENE (2011)
RMRP Is a Non-Coding RNA Essential for Early Murine Development
Joseph Rosenbluh et al.
PLOS ONE (2011)
Separation of telomerase functions by reverse genetics
Shibani Mukherjee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The p53 tumor suppressor: A master regulator of diverse cellular processes and therapeutic target in cancer
Marianne Farnebo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
MicroRNA-1285 inhibits the expression of p53 by directly targeting its 3′ untranslated region
Shu Tian et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Ribosomopathies: human disorders of ribosome dysfunction
Anupama Narla et al.
BLOOD (2010)
MicroRNA Profiling Reveals Two Distinct p53-Related Human Pluripotent Stem Cell States
Pierre Neveu et al.
CELL STEM CELL (2010)
Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome
Edenir I. Palmero et al.
CURRENT OPINION IN ONCOLOGY (2010)
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Wenwei Hu et al.
MOLECULAR CELL (2010)
A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q-syndrome
Jillian L. Barlow et al.
NATURE MEDICINE (2010)
miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma
Alexander Swarbrick et al.
NATURE MEDICINE (2010)
Comparison of mitochondrial and nucleolar RNase MRP reveals identical RNA components with distinct enzymatic activities and protein components
Qiaosheng Lu et al.
RNA (2010)
Mutant p53 Gain-of-Function in Cancer
Moshe Oren et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Architecture of inherited susceptibility to common cancer
Olivia Fletcher et al.
NATURE REVIEWS CANCER (2010)
Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma
Marta Lionetti et al.
BLOOD (2009)
Signaling to p53: Ribosomal Proteins Find Their Way
Yanping Zhang et al.
CANCER CELL (2009)
Blinded by the Light: The Growing Complexity of p53
Karen H. Vousden et al.
CELL (2009)
MicroRNA-125b is a novel negative regulator of p53
Minh T. N. Le et al.
GENES & DEVELOPMENT (2009)
Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations
Kelly D. Gonzalez et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA
Yoshiko Maida et al.
NATURE (2009)
20 years studying p53 functions in genetically engineered mice
Lawrence A. Donehower et al.
NATURE REVIEWS CANCER (2009)
p53 polymorphisms: cancer implications
Catherine Whibley et al.
NATURE REVIEWS CANCER (2009)
Identification of RPS14 as a 5q- syndrome gene by RNA interference screen
Benjamin L. Ebert et al.
NATURE (2008)
Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function
Natalie C. Jones et al.
NATURE MEDICINE (2008)
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
Flavia Pichiorri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Loss of p53 synthesis in zebrafish tumors with ribosomal protein gene mutations
Alyson W. MacInnes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Tobacco use, body mass index, and the risk of leukemia and multiple myeloma: A nationwide cohort study in Sweden
Pia Fernberg et al.
CANCER RESEARCH (2007)
Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities
Jill Dixon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Ribosomes and marrow failure: coincidental association or molecular paradigm?
Johnson M. Liu et al.
BLOOD (2006)
Prevalence of monoclonal gammopathy of undetermined significance
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A microRNA expression signature of human solid tumors defines cancer gene targets
S Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Many ribosomal protein genes are cancer genes in zebrafish
A Amsterdam et al.
PLOS BIOLOGY (2004)
Modulation of mammalian life span by the short isoform of p53
B Maier et al.
GENES & DEVELOPMENT (2004)
RNase MRP cleaves the CLB2 mRNA to promote cell cycle progression:: Novel method of mRNA degradation
T Gill et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
KP Olive et al.
CELL (2004)
Prediction of pathogenic mutations in patients with early-onset breast cancer by family history
F Lalloo et al.
LANCET (2003)
'Super p53' mice exhibit enhanced DNA damage response, are tumor resistant and age normally
I García-Cao et al.
EMBO JOURNAL (2002)
p53 mutant mice that display early ageing-associated phenotypes
SD Tyner et al.
NATURE (2002)
Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia
M Ridanpää et al.
CELL (2001)
Share Paper
